Haleh Hanifian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haleh Hanifian has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Mehdi Nateghpour
Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications Kambiz Diba
Dept. of Medical Parasitology and Mycology, Faculty of medicine, Urmia University of Medical Sciences, Urmia, Iran
3 shared publications- Ali Reza Chavshin
Social Determinants of Health, Research Center, Urmia University of Medical Sciences, Urmia, Iran
1 shared publication Atefeh Namaki
Arefian General Hospital, Urmia, Iran
1 shared publication- Eisa Kaveh Vernousfaderani
Department of Pharmacology and Toxicology, School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication Gholamreza Hassanpour
Center For Research of Endemic Parasites of Iran Tehran University of Medical Sciences (TUMS) Tehran Iran
1 shared publication
Latest Publications
- Open Access
- 20 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9) , e71631
Design, Synthesis, and Evaluation of New 1,4‐Naphthoquinone‐1,2,3‐triazoles as Antimalarial Agents
The increasing resistance to existing antimalarial agents has prompted researchers to develop new therapeutic candidates. To address this, the hybridization of 1,4‐naphthoquinone and 1,2,3‐triazole yielded a new series of compounds evaluated as prospective in vitro antimalarial agents against the chloroquine‐sensitive 3D7 and chloroquine‐resistant K1 strains of Plasmodium falciparum . The target compounds were synthesized efficiently via a multistep route, involving the reaction of 1,4‐naphthoquinone and p ‐aminobenzoic acid, followed by reactions with propargylamine and different prepared chlorides. The synthetic route was concluded using a copper(I)‐catalyzed azide‐alkyne cycloaddition (CuAAC) “click” reaction. Based on structure‐activity relationships (SAR), the compound bearing a 4‐chloroaryl moiety ( 9g ) was the most active against P. falciparum 3D7, exhibiting 60.00% growth inhibition at 25 µM. Furthermore, compound 9k bearing a 2‐methylaryl moiety exhibited the most potent activity against P. falciparum K1, showing 64.52% growth inhibition at 50 µM. In silico simulations of compound 9g on thirteen protein targets in P. falciparum indicated strong interactions with the 1J3 and 1LDG targets. Also, the stability of the ligand‐protein complexes was verified for 3FGO.
- 20 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9) , e71631
Open AccessDesign, Synthesis, and Evaluation of New 1,4‐Naphthoquinone‐1,2,3‐triazoles as Antimalarial Agents
The increasing resistance to existing antimalarial agents has prompted researchers to develop new therapeutic candidates. To address this, the hybridization of 1,4‐naphthoquinone and 1,2,3‐triazole yielded a new series of compounds evaluated as prospective in vitro antimalarial agents against the chloroquine‐sensitive 3D7 and chloroquine‐resistant K1 strains of Plasmodium falciparum . The target compounds were synthesized efficiently via a multistep route, involving the reaction of 1,4‐naphthoquinone and p ‐aminobenzoic acid, followed by reactions with propargylamine and different prepared chlorides. The synthetic route was concluded using a copper(I)‐catalyzed azide‐alkyne cycloaddition (CuAAC) “click” reaction. Based on structure‐activity relationships (SAR), the compound bearing a 4‐chloroaryl moiety ( 9g ) was the most active against P. falciparum 3D7, exhibiting 60.00% growth inhibition at 25 µM. Furthermore, compound 9k bearing a 2‐methylaryl moiety exhibited the most potent activity against P. falciparum K1, showing 64.52% growth inhibition at 50 µM. In silico simulations of compound 9g on thirteen protein targets in P. falciparum indicated strong interactions with the 1J3 and 1LDG targets. Also, the stability of the ligand‐protein complexes was verified for 3FGO.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Nanotechnology
- Vol. 2026 (1) , 9990785
Green‐Synthesized Nanoparticles as Emerging Therapeutics for Malaria: Advances, Mechanisms, and Translational Prospects
Background: Malaria remains a major global health challenge, aggravated by the increasing multidrug‐resistant Plasmodium strains and insecticide‐resistant Anopheles vectors. Although advances in nanotechnology have created new opportunities for better drug delivery, conventional nanoparticle synthesis often relies on toxic chemicals and energy‐intensive processes that limit biomedical applicability. Green synthesis, which employs plant extracts, microorganisms, algae, and biopolymers as reducing and stabilizing agents for nanoparticle production, has emerged as an environmentally sustainable strategy with considerable potential for antimalarial therapy. Methods: A comprehensive search of PubMed, Scopus, Web of Science, WHO databases, and Google Scholar was conducted for studies published between 2010 and 2025 using the keywords green synthesis , biogenic nanoparticles , antimalarial , Plasmodium , plant-mediated nanoparticles , and biopolymer nanoparticles . Eligible studies included original articles reporting synthesis, characterization, in vitro or in vivo antiplasmodial activity, or mechanistic analyses of green‐synthesized nanoparticles. Reviews, nonmalaria studies, and articles lacking experimental data were excluded. Results: A wide range of green‐synthesized nanoparticles, including silver, gold, zinc oxide, magnesium oxide, and chitosan‐based systems, have shown significant antiplasmodial activity. These nanoparticles exert their antiplasmodial effects through multiple mechanisms, including the generation of reactive oxygen species (ROS), disruption of parasite membrane integrity, inhibition of hemozoin formation and glycolytic pathways, and enhanced delivery of conventional antimalarial drugs. Both in vitro and in vivo studies have demonstrated significant reductions in parasitemia with low cytotoxicity compared with chemically synthesized nanoparticles. Green‐synthesized nanoparticles often exhibit improved stability and biocompatibility owing to natural capping agents derived from plants and microorganisms. Conclusion: Green‐synthesized nanoparticles are an effective, environmentally friendly, and mechanistically versatile platform for developing next‐generation antimalarial therapeutics. However, challenges like standardization, long‐term toxicity assessments, and pharmacokinetic profiling must be addressed before clinical procedures. Future research integrating nanotechnology and molecular parasitology strategies may accelerate the development of safer and more effective therapies against malaria.
- 1 January 2026
- Published by Wiley in Journal of Nanotechnology
- Vol. 2026 (1) , 9990785
Open AccessGreen‐Synthesized Nanoparticles as Emerging Therapeutics for Malaria: Advances, Mechanisms, and Translational Prospects
Background: Malaria remains a major global health challenge, aggravated by the increasing multidrug‐resistant Plasmodium strains and insecticide‐resistant Anopheles vectors. Although advances in nanotechnology have created new opportunities for better drug delivery, conventional nanoparticle synthesis often relies on toxic chemicals and energy‐intensive processes that limit biomedical applicability. Green synthesis, which employs plant extracts, microorganisms, algae, and biopolymers as reducing and stabilizing agents for nanoparticle production, has emerged as an environmentally sustainable strategy with considerable potential for antimalarial therapy. Methods: A comprehensive search of PubMed, Scopus, Web of Science, WHO databases, and Google Scholar was conducted for studies published between 2010 and 2025 using the keywords green synthesis , biogenic nanoparticles , antimalarial , Plasmodium , plant-mediated nanoparticles , and biopolymer nanoparticles . Eligible studies included original articles reporting synthesis, characterization, in vitro or in vivo antiplasmodial activity, or mechanistic analyses of green‐synthesized nanoparticles. Reviews, nonmalaria studies, and articles lacking experimental data were excluded. Results: A wide range of green‐synthesized nanoparticles, including silver, gold, zinc oxide, magnesium oxide, and chitosan‐based systems, have shown significant antiplasmodial activity. These nanoparticles exert their antiplasmodial effects through multiple mechanisms, including the generation of reactive oxygen species (ROS), disruption of parasite membrane integrity, inhibition of hemozoin formation and glycolytic pathways, and enhanced delivery of conventional antimalarial drugs. Both in vitro and in vivo studies have demonstrated significant reductions in parasitemia with low cytotoxicity compared with chemically synthesized nanoparticles. Green‐synthesized nanoparticles often exhibit improved stability and biocompatibility owing to natural capping agents derived from plants and microorganisms. Conclusion: Green‐synthesized nanoparticles are an effective, environmentally friendly, and mechanistically versatile platform for developing next‐generation antimalarial therapeutics. However, challenges like standardization, long‐term toxicity assessments, and pharmacokinetic profiling must be addressed before clinical procedures. Future research integrating nanotechnology and molecular parasitology strategies may accelerate the development of safer and more effective therapies against malaria.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1)
Iran’s Journey Through Malaria: From Past Challenges to Future Elimination—A Narrative Review
Background: Malaria remains a persistent public health concern in Iran, particularly in southeastern regions bordering Afghanistan and Pakistan. Despite substantial progress over recent decades, challenges such as cross‐border transmission, insecticide resistance, and health system disruptions continue to threaten elimination goals. Methods: This narrative review synthesized evidence from the World Health Organization (WHO) World Malaria Reports, national surveillance summaries, and peer‐reviewed publications indexed in PubMed and Scopus from 2000 to 2025. Emphasis was placed on case trends, intervention coverage, and cross‐border dynamics. Results: Iran reduced indigenous malaria cases dramatically from thousands in the early 2000s to fewer than 300 annually by the mid‐2010s and subsequently recorded multiple consecutive years with zero indigenous transmission, according to the WHO surveillance reports. Key achievements included integrated vector management, community engagement, and strengthened cross‐border initiatives. However, interruptions during the COVID‐19 pandemic and a resurgence of malaria in 2022, largely associated with imported infections, operational disruptions, and emerging vector threats, highlighted vulnerabilities in elimination‐phase systems. Additional challenges such as insecticide resistance and the spread of Anopheles stephensi further complicate the elimination trajectory. Conclusion: Iran’s experience illustrates the need for adaptive, multisectoral approaches to malaria control in complex socioecological settings. While elimination remains within reach, achieving the WHO certification will require transparent surveillance metrics, reinforce cross‐border collaboration, and sustain political and financial commitment.
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1)
Open AccessIran’s Journey Through Malaria: From Past Challenges to Future Elimination—A Narrative Review
Background: Malaria remains a persistent public health concern in Iran, particularly in southeastern regions bordering Afghanistan and Pakistan. Despite substantial progress over recent decades, challenges such as cross‐border transmission, insecticide resistance, and health system disruptions continue to threaten elimination goals. Methods: This narrative review synthesized evidence from the World Health Organization (WHO) World Malaria Reports, national surveillance summaries, and peer‐reviewed publications indexed in PubMed and Scopus from 2000 to 2025. Emphasis was placed on case trends, intervention coverage, and cross‐border dynamics. Results: Iran reduced indigenous malaria cases dramatically from thousands in the early 2000s to fewer than 300 annually by the mid‐2010s and subsequently recorded multiple consecutive years with zero indigenous transmission, according to the WHO surveillance reports. Key achievements included integrated vector management, community engagement, and strengthened cross‐border initiatives. However, interruptions during the COVID‐19 pandemic and a resurgence of malaria in 2022, largely associated with imported infections, operational disruptions, and emerging vector threats, highlighted vulnerabilities in elimination‐phase systems. Additional challenges such as insecticide resistance and the spread of Anopheles stephensi further complicate the elimination trajectory. Conclusion: Iran’s experience illustrates the need for adaptive, multisectoral approaches to malaria control in complex socioecological settings. While elimination remains within reach, achieving the WHO certification will require transparent surveillance metrics, reinforce cross‐border collaboration, and sustain political and financial commitment.
- 28 December 2025
- Published by Wiley in Parasite Immunology
- Vol. 48 (1) , e70046
Essential Trace Elements and Their Impact on Immune Response and Disease Severity in Malaria Infection: A Systematic Review
Malaria remains a major global health challenge, profoundly influencing host nutritional and immune status. Essential trace elements such as iron, zinc, copper and magnesium play pivotal roles in immune regulation, antioxidant defence, and pathogen control. However, their alterations during malaria infection and implications for disease outcome have been inconsistently reported. This systematic review aimed to synthesise current evidence on serum and plasma concentrations of key trace elements in malaria‐infected individuals and experimental models, and to evaluate their relationship with immune responses, disease severity, and treatment outcomes. A systematic search was conducted in various academic databases, including PubMed, Web of Science, Scopus, and Google Scholar for studies published from January 2010 to November 2025. The quality assessment of the studies was done using the Critical Appraisal Skills Programme (CASP) tool. The review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines to ensure a comprehensive and transparent process. Across human and experimental studies, malaria infection was consistently associated with reduced serum concentrations of iron, zinc, and magnesium, while copper levels showed variable trends, often elevated in acute infection, reflecting an inflammatory response. These alterations were linked to dysregulated cytokine production, particularly increased TNF‐α and IL‐10, higher parasitemia, and worsened clinical outcomes. Zinc supplementation improved micronutrient status but showed limited impact on malaria incidence. Emerging spectrometric approaches demonstrated utility in trace element profiling for malaria diagnosis and prognosis. Malaria‐induced disturbances in trace element homeostasis, notably reduced iron, zinc, and magnesium, and altered copper levels, contribute to immune dysfunction and oxidative stress, aggravating disease severity. Integrating targeted micronutrient interventions with antimalarial therapy may enhance host immune competence and improve treatment outcomes.
- 28 December 2025
- Published by Wiley in Parasite Immunology
- Vol. 48 (1) , e70046
Essential Trace Elements and Their Impact on Immune Response and Disease Severity in Malaria Infection: A Systematic Review
Malaria remains a major global health challenge, profoundly influencing host nutritional and immune status. Essential trace elements such as iron, zinc, copper and magnesium play pivotal roles in immune regulation, antioxidant defence, and pathogen control. However, their alterations during malaria infection and implications for disease outcome have been inconsistently reported. This systematic review aimed to synthesise current evidence on serum and plasma concentrations of key trace elements in malaria‐infected individuals and experimental models, and to evaluate their relationship with immune responses, disease severity, and treatment outcomes. A systematic search was conducted in various academic databases, including PubMed, Web of Science, Scopus, and Google Scholar for studies published from January 2010 to November 2025. The quality assessment of the studies was done using the Critical Appraisal Skills Programme (CASP) tool. The review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines to ensure a comprehensive and transparent process. Across human and experimental studies, malaria infection was consistently associated with reduced serum concentrations of iron, zinc, and magnesium, while copper levels showed variable trends, often elevated in acute infection, reflecting an inflammatory response. These alterations were linked to dysregulated cytokine production, particularly increased TNF‐α and IL‐10, higher parasitemia, and worsened clinical outcomes. Zinc supplementation improved micronutrient status but showed limited impact on malaria incidence. Emerging spectrometric approaches demonstrated utility in trace element profiling for malaria diagnosis and prognosis. Malaria‐induced disturbances in trace element homeostasis, notably reduced iron, zinc, and magnesium, and altered copper levels, contribute to immune dysfunction and oxidative stress, aggravating disease severity. Integrating targeted micronutrient interventions with antimalarial therapy may enhance host immune competence and improve treatment outcomes.
- Open Access
- 1 January 2014
- Published by Medknow in Indian Journal of Pathology and Microbiology
- Vol. 57 (3) , 442-444
Human parvovirus B19 in Iranian pregnant women: A serologic survey
Background: Parvovirus B19 infection is associated with clinical symptoms that vary in the spectrum from trivial to severe. The important clinical manifestations are erythema infectiosum or the fifth disease, transient aplastic anemia in patients with hemoglobinopathies, acute polyarthralgia syndrome in adults, hydrops fetalis, spontaneous abortion and stillbirth. Acute infection in nonimmune pregnant women can lead to fetal hydrops. In view of the many complications that can result from acute parvovirus B19 infections during pregnancy, documenting the seroprevalence of anti-parvovirus B19 IgG and its association with the history of abortion in an Iranian population of pregnant women would be of value. Materials and Methods: Serum samples from 86 pregnant women were collected between May and September 2011 in West Azerbaijan province of Iran. Every pregnant woman completed a questionnaire which included age, history of tattooing, blood transfusion, and abortion. Anti-B19 specific IgG was detected by using commercial enzyme-linked immunosorbent assays. Results: Anti-B19-specific IgG antibody was detected in (65/86, 75.6%) of pregnant women. The mean age was 25.56 ± 5.30 years and three women had a documented history of blood transfusion (2 of them tested seropositive for B19). 16/18 (88.8%) of women with a history of abortion were IgG positive. The frequency of abortion sessions in the seropositive group (25 sessions of abortion: 11 women experienced once, 2 twice, 2 thrice and one 4 times) was 4.03 times greater than abortion in seronegative group (2 abortions/21 seronegative women). Conclusion: Our study reaffirms previous reports regarding the higher frequency of abortion among anti-B19 IgG seropositive pregnant women and a possible role of this viral infection in the pathogenesis of abortion.
- 1 January 2014
- Published by Medknow in Indian Journal of Pathology and Microbiology
- Vol. 57 (3) , 442-444
Open AccessHuman parvovirus B19 in Iranian pregnant women: A serologic survey
Background: Parvovirus B19 infection is associated with clinical symptoms that vary in the spectrum from trivial to severe. The important clinical manifestations are erythema infectiosum or the fifth disease, transient aplastic anemia in patients with hemoglobinopathies, acute polyarthralgia syndrome in adults, hydrops fetalis, spontaneous abortion and stillbirth. Acute infection in nonimmune pregnant women can lead to fetal hydrops. In view of the many complications that can result from acute parvovirus B19 infections during pregnancy, documenting the seroprevalence of anti-parvovirus B19 IgG and its association with the history of abortion in an Iranian population of pregnant women would be of value. Materials and Methods: Serum samples from 86 pregnant women were collected between May and September 2011 in West Azerbaijan province of Iran. Every pregnant woman completed a questionnaire which included age, history of tattooing, blood transfusion, and abortion. Anti-B19 specific IgG was detected by using commercial enzyme-linked immunosorbent assays. Results: Anti-B19-specific IgG antibody was detected in (65/86, 75.6%) of pregnant women. The mean age was 25.56 ± 5.30 years and three women had a documented history of blood transfusion (2 of them tested seropositive for B19). 16/18 (88.8%) of women with a history of abortion were IgG positive. The frequency of abortion sessions in the seropositive group (25 sessions of abortion: 11 women experienced once, 2 twice, 2 thrice and one 4 times) was 4.03 times greater than abortion in seronegative group (2 abortions/21 seronegative women). Conclusion: Our study reaffirms previous reports regarding the higher frequency of abortion among anti-B19 IgG seropositive pregnant women and a possible role of this viral infection in the pathogenesis of abortion.
- Open Access
- 1 July 2013
- Vol. 8 (3) , 376-381
Identification of Echinococcus granulosus Strains in Isolated Hydatid Cyst Specimens from Animals by PCR-RFLP Method in West Azerbaijan – Iran
The aim of this study was DNA extraction from protoscolecses of Echinococcus granulosus and identification of these strains in West-Azerbaijan Province, north western Iran. Thirty one livestock isolates from sheep and cattle were collected from abattoirs of the province. To investigate the genetic variation of the isolates, after DNA extraction by Glass beads-phenol chloroform method; PCR-RLFP analysis of rDNA-ITS1 was performed using three different restriction enzymes of Taq 1, Rsa 1 and Alu 1. Amplified PCR products for all isolates were 1000bp band which is expected band in sheep strains (G1-G3 complex). The results of RFLP analysis also were the same for all isolates. PCR-RFLP patterns restriction enzymes were identical as follows, Rsa1 bands under UV showed two bands approximately 655bp and 345bp. Alu1 bands were as follows: two approximately 800bp and 200bp and Taq1 did not cut any region and bands were approximately 1000 bp in all samples. Based on PCR-RFLP patterns of ITS1 fragment produced with endonucleases enzyme digestion in animal isolates, it can be concluded that a single strain of E. granulosus (sheep strain or G1-G3 complex) is dominant genotype in this province.
- 1 July 2013
- Vol. 8 (3) , 376-381
Open AccessIdentification of Echinococcus granulosus Strains in Isolated Hydatid Cyst Specimens from Animals by PCR-RFLP Method in West Azerbaijan – Iran
The aim of this study was DNA extraction from protoscolecses of Echinococcus granulosus and identification of these strains in West-Azerbaijan Province, north western Iran. Thirty one livestock isolates from sheep and cattle were collected from abattoirs of the province. To investigate the genetic variation of the isolates, after DNA extraction by Glass beads-phenol chloroform method; PCR-RLFP analysis of rDNA-ITS1 was performed using three different restriction enzymes of Taq 1, Rsa 1 and Alu 1. Amplified PCR products for all isolates were 1000bp band which is expected band in sheep strains (G1-G3 complex). The results of RFLP analysis also were the same for all isolates. PCR-RFLP patterns restriction enzymes were identical as follows, Rsa1 bands under UV showed two bands approximately 655bp and 345bp. Alu1 bands were as follows: two approximately 800bp and 200bp and Taq1 did not cut any region and bands were approximately 1000 bp in all samples. Based on PCR-RFLP patterns of ITS1 fragment produced with endonucleases enzyme digestion in animal isolates, it can be concluded that a single strain of E. granulosus (sheep strain or G1-G3 complex) is dominant genotype in this province.
- Open Access
- 1 June 2012
- Published by Galenos Yayinevi in Turkish Journal of Parasitology
- Vol. 36 (2) , 100-104
Comparison of Four Methods for DNA Extraction From Echinococcus granulosus Protoscoleces
Cystic echinococcosis caused by the dog tapeworm Echinococcus granulosus, is a global zoonotic infection which is economically important and constitutes a major threat to public health in many countries, especially in Middle Eastern countries. Strain characterization is essential for the establishment of a preventive and control strategy in every endemic area. Before all molecular studies, it is necessary to achieve DNA of the parasite. The aim of this study was to compare four simple methods of DNA extraction from protoscolecses of E. granulosus in samples from the West Azerbaijan province of Iran. After collecting sheep and cow hydatid cysts from several slaughterhouses of the province, DNA samples were extracted using four different methods involving the use of glass beads, commercial DNA extraction kit, boiling and crushing. For all DNA samples extracted, electrophoresis on 1.3% agarose gel was performed. The methods were compared regarding DNA, time and cost effectiveness and facility. All methods showed some advantages and disadvantages. The commercial kit method, which was the most time and cost effectiveness method, achieved no bands and glass beads method had the best results on gel electrophoresis. Glass beads and boiling methods were the most suitable methods regarding their ease, quickness and cost effectiveness.
- 1 June 2012
- Published by Galenos Yayinevi in Turkish Journal of Parasitology
- Vol. 36 (2) , 100-104
Open AccessComparison of Four Methods for DNA Extraction From Echinococcus granulosus Protoscoleces
Cystic echinococcosis caused by the dog tapeworm Echinococcus granulosus, is a global zoonotic infection which is economically important and constitutes a major threat to public health in many countries, especially in Middle Eastern countries. Strain characterization is essential for the establishment of a preventive and control strategy in every endemic area. Before all molecular studies, it is necessary to achieve DNA of the parasite. The aim of this study was to compare four simple methods of DNA extraction from protoscolecses of E. granulosus in samples from the West Azerbaijan province of Iran. After collecting sheep and cow hydatid cysts from several slaughterhouses of the province, DNA samples were extracted using four different methods involving the use of glass beads, commercial DNA extraction kit, boiling and crushing. For all DNA samples extracted, electrophoresis on 1.3% agarose gel was performed. The methods were compared regarding DNA, time and cost effectiveness and facility. All methods showed some advantages and disadvantages. The commercial kit method, which was the most time and cost effectiveness method, achieved no bands and glass beads method had the best results on gel electrophoresis. Glass beads and boiling methods were the most suitable methods regarding their ease, quickness and cost effectiveness.
- 1 January 2012
- Published by The Japanese Society for Medical Mycology in Medical Mycology Journal
- Vol. 53 (3) , 193-198
Rapid Identification of Drug Resistant Candida Species Causing Recurrent Vulvovaginal Candidiasis
Some yeast agents including Candida albicans, Candida tropicalis and Candida glabrata have a role in recurrent vulvovaginal candidiasis. We studied the frequency of both common and recurrent vulvovaginal candidiasis in symptomatic cases which were referred to Urmia Medical Sciences University related gynecology clinics using morphologic and molecular methods. The aim of this study was the identification of Candida species isolated from recurrent vulvovaginal candidiasis cases using a rapid and reliable molecular method. Vaginal swabs obtained from each case, were cultured on differential media including cornmeal agar and CHROM agar Candida. After 48 hours at 37℃, the cultures were studied for growth characteristics and color production respectively. All isolates were identified using the molecular method of PCR - restriction fragment length polymorphism. Among all clinical specimens, we detected 19 ( 16 % ) non fungal agents, 87 ( 82.1 % ) yeasts and 2 ( 1.9 % ) multiple infections. The yeast isolates identified morphologically included Candida albicans ( n = 62 ), Candida glabrata ( n = 9 ), Candida tropicalis ( n = 8 ), Candida parapsilosis ( n = 8 ) and Candida guilliermondii and Candida krusei ( n = 1 each ). We also obtained very similar results for Candida albicans, Candida glabrata and Candida tropicalis as the most common clinical isolates, by using PCR - Restriction Fragment Length Polymorphism. Use of two differential methods, morphologic and molecular, enabled us to identify most medically important Candida species which particularly cause recurrent vulvovaginal candidiasis.
- 1 January 2012
- Published by The Japanese Society for Medical Mycology in Medical Mycology Journal
- Vol. 53 (3) , 193-198
Rapid Identification of Drug Resistant Candida Species Causing Recurrent Vulvovaginal Candidiasis
Some yeast agents including Candida albicans, Candida tropicalis and Candida glabrata have a role in recurrent vulvovaginal candidiasis. We studied the frequency of both common and recurrent vulvovaginal candidiasis in symptomatic cases which were referred to Urmia Medical Sciences University related gynecology clinics using morphologic and molecular methods. The aim of this study was the identification of Candida species isolated from recurrent vulvovaginal candidiasis cases using a rapid and reliable molecular method. Vaginal swabs obtained from each case, were cultured on differential media including cornmeal agar and CHROM agar Candida. After 48 hours at 37℃, the cultures were studied for growth characteristics and color production respectively. All isolates were identified using the molecular method of PCR - restriction fragment length polymorphism. Among all clinical specimens, we detected 19 ( 16 % ) non fungal agents, 87 ( 82.1 % ) yeasts and 2 ( 1.9 % ) multiple infections. The yeast isolates identified morphologically included Candida albicans ( n = 62 ), Candida glabrata ( n = 9 ), Candida tropicalis ( n = 8 ), Candida parapsilosis ( n = 8 ) and Candida guilliermondii and Candida krusei ( n = 1 each ). We also obtained very similar results for Candida albicans, Candida glabrata and Candida tropicalis as the most common clinical isolates, by using PCR - Restriction Fragment Length Polymorphism. Use of two differential methods, morphologic and molecular, enabled us to identify most medically important Candida species which particularly cause recurrent vulvovaginal candidiasis.